Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · IEX Real-Time Price · USD
19.42
-0.95 (-4.66%)
At close: Jul 19, 2024, 4:00 PM
19.70
+0.28 (1.44%)
Pre-market: Jul 22, 2024, 7:22 AM EDT
Hims & Hers Health Employees
Hims & Hers Health had 1,046 employees as of December 31, 2023. The number of employees increased by 395 or 60.68% compared to the previous year.
Employees
1,046
Change (1Y)
395
Growth (1Y)
60.68%
Revenue / Employee
$917,209
Profits / Employee
-$2,248
Market Cap
4.01B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,046 | 395 | 60.68% |
Dec 31, 2022 | 651 | 253 | 63.57% |
Dec 31, 2021 | 398 | 217 | 119.89% |
Dec 31, 2020 | 181 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Coca-Cola FEMSA | 104,241 |
Graham Holdings Company | 19,901 |
Flowers Foods | 9,300 |
Primo Water | 9,240 |
Grand Canyon Education | 5,800 |
Lancaster Colony | 3,400 |
The Boston Beer Company | 2,793 |
National Beverage | 1,559 |
HIMS News
- 6 days ago - Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024 - Business Wire
- 11 days ago - Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong' - CNBC
- 21 days ago - Hims & Hers shares plunge 12% amid allegations of GLP-1 drug sourcing from ‘shady supplier' - Fast Company
- 2 months ago - Hims & Hers rolls out weight-loss shots much cheaper than Ozempic, Wegovy - Fox Business
- 2 months ago - Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortages - Fast Company
- 2 months ago - Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs - Investopedia
- 2 months ago - Hims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To Wegovy - Forbes
- 2 months ago - Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings - Market Watch